5-Bromothieno[2,3-b]pyridine-2-carboxylic acid

Catalog No. :
ACERNV539
CAS No. :
1242336-81-7
Molecular Formula :
C8H4BrNO2S
Molecular Weight :
258.10

IUPAC Name:5-bromothieno[2,3-b]pyridine-2-carboxylic acid

5-Bromothieno[2,3-b]pyridine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$83.00Login to see priceIn stockInquiry
1g97%$232.00Login to see priceIn stockInquiry
5g97%$696.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromothieno[2,3-b]pyridine-2-carboxylic acid
IUPAC Name5-bromothieno[2,3-b]pyridine-2-carboxylic acid
MDL No.MFCD17016095
Molecular FormulaC8H4BrNO2S
Molecular Weight258.10
SMILESO=C(C1=CC2=CC(Br)=CN=C2S1)O
InChI KeyPNXKVMHKFZDENP-UHFFFAOYSA-N
Synonym5-BROMOTHIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID | 1242336-81-7 | Thieno[2,3-b]pyridine-2-carboxylic acid, 5-bromo- | MFCD17016095 | SCHEMBL13977425 | DTXSID50744129 | AKOS023775783 | PB24309 | AS-41825 | SY118947 | CS-0050555 | EN300-227581 | 5-BROMOTHIENO[2,3-B]PYRIDINE-2-CARBOX
CAS No.1242336-81-7
PubChem CID71042699

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACERNV539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGAO478 route compound structure diagram
    ACWGAO4781234615-97-4 In Stock
  2. Then
  3. ACERNV539 route product structure diagram
    ACERNV5391242336-81-7 In Stock
Inquiry

2. ACERNV539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACERNV539 route product structure diagram
    ACERNV5391242336-81-7 In Stock
Inquiry

Comments (0)